Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study
Pharmaceuticals · 19.03.2025 · 18 (3) · 433
DOI: 10.3390/ph18030433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.03.2025. Verfasst von Arif Jamal Siddiqui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at University of Ha'il - Saudi Arabia, Scientific Research Deanship at the University of Ha’il—Saudi Arabia.
Abstract (Originalsprache)
Background/Objectives: The present study investigated the anticancer potential of Asparagus racemosus Willd. against triple-negative breast cancer (TNBC) using a combined in silico and in vitro approach.
Methods
Network pharmacology identified 115 potential targets shared between A. racemosus phytochemicals and TNBC, highlighting key cancer-related pathways. Molecular docking predicted strong binding affinities between specific phytochemicals (beta-sitosterol, quercetin, and others) and crucial TNBC targets, including AKT1 and ERBB2.
Results
Molecular dynamics simulations validated these interactions, demonstrating stable complex formation. In vitro, A. racemosus crude extracts exhibited potent anticancer activity against MDA-MB-231 TNBC cells, showing a dose-dependent reduction in viability (IC50 = 90.44 μg/mL), induction of G1 phase cell cycle arrest, and significant early apoptosis.
Conclusions
These integrated findings provide compelling evidence for the anticancer potential of A. racemosus against TNBC, suggesting its promise for further development as a therapeutic strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, College of Science, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Research and Development Cell (RDC), Parul University, Waghodia, Vadodara 391760, Gujarat, India.
- Department of Biotechnology, Parul Institute of Applied Sciences, Parul University, Waghodia, Vadodara 391760, Gujarat, India.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Ha'il, Ha'il P.O. Box 2440, Saudi Arabia.
- Department of Biophysics, University of Delhi, South Campus, New Delhi 110021, India.
ORCID-Profile: Arif Jamal Siddiqui, Salem Elkahoui, Mitesh Patel, Riadh Badraoui, Mohd Adnan
Förderung
- Scientific Research Deanship at University of Ha'il - Saudi Arabia
- Scientific Research Deanship at the University of Ha’il—Saudi Arabia
Zitieren
APA
Siddiqui, A. J., Elkahoui, S., Alshammari, A. M., Patel, M., Ghoniem, A. E. M., Abdalla, R. A. H., Dwivedi-Agnihotri, H., Badraoui, R., & Adnan, M. (2025). Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study. Pharmaceuticals, 18(3), 433. https://doi.org/10.3390/ph18030433
Vancouver
Siddiqui AJ, Elkahoui S, Alshammari AM, Patel M, Ghoniem AEM, Abdalla RAH, et al. Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study. Pharmaceuticals. 2025;18(3):433. doi:10.3390/ph18030433
BibTeX
@article{Siddiqui2025,
author = {Siddiqui, Arif Jamal and Elkahoui, Salem and Alshammari, Ahmed Mohajja and Patel, Mitesh and Ghoniem, Ahmed Eisa Mahmoud and Abdalla, Randa Abdeen Husien and Dwivedi-Agnihotri, Hemlata and Badraoui, Riadh and Adnan, Mohd},
title = {Mechanistic Insights into the Anticancer Potential of Asparagus racemosus Willd. Against Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Study},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {3},
pages = {433},
doi = {10.3390/ph18030433}
}
EUVIMED